CheckMate 227: Nivolumab + ipilimumab vs chemotherapy as 1L treatment for advanced NSCLC with high tumor mutational burden Meeting Abstract
| Authors: | Mathias, C.; Reck, M.; Hellmann, M.; Ramalingam, S.; Brahmer, J.; O'Byrne, K.; Bhagavatheeswaran, P.; Nathan, F.; Borghaei, H.; Paz-Ares, L. |
| Abstract Title: | CheckMate 227: Nivolumab + ipilimumab vs chemotherapy as 1L treatment for advanced NSCLC with high tumor mutational burden |
| Meeting Title: | IASLC Latin America Conference on Lung Cancer 2018 |
| Keywords: | patient-reported outcomes; nsclc; nivolumab; tumor mutational burden |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 13 |
| Issue: | 9 Suppl. |
| Meeting Dates: | 2018 Aug 15-18 |
| Meeting Location: | Cordoba, Argentina |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-09-01 |
| Start Page: | S152 |
| End Page: | S153 |
| Language: | English |
| ACCESSION: | WOS:000444519200003 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2018.07.021 |
| Notes: | Meeting Abstract: PS2 -- Source: Wos |
